We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

4 hedge funds and large institutions have $7.5M invested in Plus Therapeutics in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 5 → 4 (-1)

33% less capital invested

Capital invested by funds: $11.1M → $7.5M (-$3.62M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$76K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GCM
Goldman Capital Management
New York
-$1.36M
2
Renaissance Technologies
Renaissance Technologies
New York
-$321K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$45K
4
GS
Gagnon Securities
New York
-$38K
5
AC
Amici Capital
New York
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$1.45M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.14M – – –
BFA
3
BlackRock Fund Advisors
California
$920K – – –
Goldman Sachs
4
Goldman Sachs
New York
$469K – – –
State Street
5
State Street
Massachusetts
$435K – – –
Northern Trust
6
Northern Trust
Illinois
$359K – – –
PCM
7
Perkins Capital Management
Minnesota
$293K – – –
GCM
8
Goldman Capital Management
New York
$204K -$1.36M -1 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
$171K – – –
MCM
10
Marathon Capital Management
Maryland
$171K – – –
PCMI
11
Princeton Capital Management Inc
New Jersey
$171K – – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$160K – – –
TCIM
13
TIAA CREF Investment Management
New York
$128K – – –
BIM
14
BlackRock Investment Management
Delaware
$112K – – –
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$87K – – –
RAM
16
Redmond Asset Management
Virginia
$82K – – –
VKH
17
Virtu KCG Holdings
New York
$73K – – –
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$71K – – –
CB
19
Commerce Bank
Missouri
$67K – – –
Adage Capital Partners
20
Adage Capital Partners
Massachusetts
$61K – – –
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$61K – – –
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$59K – – –
Morgan Stanley
23
Morgan Stanley
New York
$58K – – –
CS
24
Credit Suisse
Switzerland
$53K – – –
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$50K – – –
1
2 3 4

PSTV Hedge Fund Activity: Q4 2014 in Review

4 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q4 2014, worth a combined $7.5M — down 33% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PSTV and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Goldman Capital Management, exiting entirely with an estimated $1.36M sold.

  • 4 institutional investors held Plus Therapeutics (PSTV) as of Q4 2014, down from 5 in Q3 2014.
  • Funds reported $7.5M of Plus Therapeutics stock for Q4 2014, down 33% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q4 2014 and 1 closed out, a net change of -1 holder.
  • The largest Plus Therapeutics seller in Q4 2014 was Goldman Capital Management, an estimated $1.36M sold.

Based on aggregated 13F filings for Q4 2014.